Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Athersys
Athersys
Athersys inches closer to bankruptcy as stroke cell therapy fails interim analysis
Fierce Biotech
Tue, 10/10/23 - 11:52 pm
Athersys
stroke
ischemic stroke
MultiStem
cell therapy
Athersys loses $100M funding deal as C-suite exits allow backer to turn tail
Fierce Biotech
Fri, 07/8/22 - 10:53 am
Athersys
funding
Prettying itself up for partners, Athersys lays off 70% of staff and most of C-suite
Fierce Biotech
Fri, 06/3/22 - 09:09 am
Athersys
layoffs
cell therapy
stem cells
Stem Cells May Help COVID-19 and ARDS Patients Breathe Easier
BioSpace
Tue, 09/15/20 - 11:34 pm
COVID-19
ARDS
Athersys
stem cells
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 05/19/19 - 03:59 pm
Incyte
Novartis
Athersys
ResTORbio
Bellerophon Therapeutics
Eli Lilly
CymaBay
Bicycle Therapeutics
Peloton Therapeutics
Ideaya
IPOs
Here's Why Athersys Is Soaring Today
Motley Fool
Tue, 04/23/19 - 11:01 pm
Athersys
Japan
clinical trials
stem cells
MultiStem
ARDS
Athersys And Aurinia Target Human And Animal Health
Seeking Alpha
Tue, 06/27/17 - 09:36 am
Athersys
Aurinia Pharmaceuticals
animal health
stem cells
5 biotech CEOs on payers, investors and big bets
BioPharma Dive
Fri, 03/10/17 - 09:42 am
biotech
payers
investors
Gil Van Bokkelen
Athersys
Robert McNeil
DalCor Pharmaceuticals
Pierre Belichard
Enterome
Michael Metzger
Syndax
Spiro Rombotis
Cyclacel
Athersys posts fourth-quarter profit of $3.6 million
Yahoo/AP
Fri, 03/11/16 - 09:34 am
Athersys
earnings
Athersys stroke treatment fails mid-stage study
Yahoo/Reuters
Fri, 04/17/15 - 10:28 am
Athersys
stroke
MultiStem
As PhII data looms, Chugai inks a $205M stem cell deal with Athersys
Fierce Biotech
Mon, 03/2/15 - 09:48 pm
Chugai
stem cells
Athersys
The Biggest Biotech Catastrophes of the Week
Motley Fool
Wed, 05/7/14 - 03:36 pm
biotech
vintafolide
Endocyte
OncoGenex
custirsen
Athersys
MultiStem
Athersys stem-cell therapy for bowel disease fails in study
Yahoo/Reuters
Mon, 04/28/14 - 08:53 am
Athersys
stem cells
inflammatory bowel disease
Pfizer
MultiStem
3 Biotechs Expecting Top Line Phase 2 Data Mid 2014
Seeking Alpha
Wed, 03/26/14 - 07:59 am
Biota Pharmaceuticals
Laninamivir Octanoate
Flu
Inovio
VGX-3100
DNA vaccines
MultiStem
Athersys
Pfizer
ulcerative colitis
2 Cell Therapy Companies That Could Thrive With Cardiovascular Disease Treatments
Seeking Alpha
Mon, 02/24/14 - 11:11 am
stem cells
cardiovascular disease
Athersys
NeoStem
AMR-001
MultiStem
Athersys: Two Crucial Near-Term Events
Seeking Alpha
Wed, 02/19/14 - 12:47 pm
Athersys
MultiStem
stem cells
Osiris
RTI Surgical
Neuralstem, StemCells, Inc., And Athersys, Inc. - Making Early Headlines In 2014
Seeking Alpha
Fri, 01/24/14 - 10:19 am
Neuralstem
StemCells
stem cells
Athersys
Athersys-Pfizer Investors: Anticipating A Phase III Trial For Inflammatory Bowel Disease
Seeking Alpha
Wed, 01/22/14 - 05:16 pm
Athersys
inflammatory bowel disease
MAPCs
Pfizer
Athersys, Inc. And The Future Of Regenerative Medicine
Seeking Alpha
Tue, 01/21/14 - 09:43 am
Athersys
regenerative medicine
3 Companies Banking on Regenerative Medicine
Wall St Cheat Sheet
Mon, 01/13/14 - 02:44 pm
regenerative medicine
Cellular Dynamics
Cytori
Athersys
Pages
1
2
3
next ›
last »